Most heart attacks don’t come out of nowhere. A new tool shows why

A new diagnostic tool shows that most heart attacks are preceded by detectable changes rather than occurring spontaneously, implying opportunities for earlier intervention and risk stratification. If validated and adopted, the finding could shift demand toward diagnostics and preventive cardiology solutions, benefiting medtech and biotech firms focused on imaging and risk-assessment tools. Near-term market impact is limited, but clinical adoption could create multi‑year revenue upside for companies in diagnostics and cardiovascular prevention.

Analysis

A new diagnostic tool shows that most heart attacks are preceded by detectable changes rather than occurring spontaneously, implying opportunities for earlier intervention and risk stratification. If validated and adopted, the finding could shift demand toward diagnostics and preventive cardiology solutions, benefiting medtech and biotech firms focused on imaging and risk-assessment tools. Near-term market impact is limited, but clinical adoption could create multi‑year revenue upside for companies in diagnostics and cardiovascular prevention.